REGENERON PHARMACEUTICALS, INC. (REGN)
Pharmaceutical Preparations · Pharmaceutical Preparations · NASDAQ
$852.03
+3.42%
Investru Score
62.5 / 100
Good
Why is REGN moving?
REGN is up 3.42% today, amid an otherwise sideways trend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Want the complete AI research memo? Unlock full stock analysis →
Score breakdown
- Financial Quality
- 60
- Growth
- 32
- Profitability
- 53
- Balance Sheet
- 97
- Valuation
- 67
- Momentum
- 85
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 13.6%
- ROE
- 14.4%
- FCF Margin
- 28.4%
- Free Cash Flow (TTM)
- $4.1B
- Earnings Quality (OCF ÷ Net Income)
- 1.1x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- -0.3x
- FCF Yield
- Data unavailable
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $12.23
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-07-30
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-04-29
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-04
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-10-28
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-08-01
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-05
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-05
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-06
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-07
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $0 · 52-week range $541.00–$854.49 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2018-05-03
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze REGN with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.